These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1322 related articles for article (PubMed ID: 15049963)

  • 1. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired prolactin deficiency indicates severe hypopituitarism in patients with disease of the hypothalamic-pituitary axis.
    Mukherjee A; Murray RD; Columb B; Gleeson HK; Shalet SM
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):743-8. PubMed ID: 14974916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
    Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease.
    Flitsch J; Knappe UJ; Lüdecke DK
    Zentralbl Neurochir; 2003; 64(1):6-11. PubMed ID: 12582940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease.
    Patil CG; Veeravagu A; Prevedello DM; Katznelson L; Vance ML; Laws ER
    Neurosurgery; 2008 Aug; 63(2):266-70; discussion 270-1. PubMed ID: 18797356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypopituitarism in Cushing's disease.
    Cavagnini F; Scacchi M; Pecori Giraldi F
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):44-7. PubMed ID: 19020385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra- and postoperative plasma ACTH concentrations in patients with Cushing's disease cured by transsphenoidal pituitary surgery.
    Czirják S; Bezzegh A; Gál A; Rácz K
    Acta Neurochir (Wien); 2002 Oct; 144(10):971-7; discussion 977. PubMed ID: 12382124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone status following treatment for Cushing's syndrome.
    Hughes NR; Lissett CA; Shalet SM
    Clin Endocrinol (Oxf); 1999 Jul; 51(1):61-6. PubMed ID: 10468966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease.
    Acebes JJ; Martino J; Masuet C; Montanya E; Soler J
    Acta Neurochir (Wien); 2007; 149(5):471-7; discussion 477-9. PubMed ID: 17406780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
    Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies of the basal secretion and the response to TRH (thyrotropin-relapsing factor) of TSH (thyrotropin) and prolactin in Cushing's syndrome and Nelson's syndrome (author's transl)].
    Luton JP; Molinie P; Strauch G; Guilhaume B; Bricaire H
    Sem Hop; 1981 May 8-15; 57(17-18):841-9. PubMed ID: 6262921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.
    van Aken MO; Pereira AM; van den Berg G; Romijn JA; Veldhuis JD; Roelfsema F
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):765-72. PubMed ID: 15163342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FSH-producing macroadenoma associated in a patient with Cushing's disease.
    Oyama K; Yamada S; Hukuhara N; Hiramatsu R; Taguchi M; Yazawa M; Matsuda A; Ohmura E; Imai Y
    Neuro Endocrinol Lett; 2006 Dec; 27(6):733-6. PubMed ID: 17187002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of recovery of adrenocortical function after treatment for Cushing's syndrome due to pituitary or adrenal adenomas.
    Klose M; Jørgensen K; Kristensen LØ
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):394-9. PubMed ID: 15355458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of Cushing's disease.
    Fehm HL; Voigt KH
    Pathobiol Annu; 1979; 9():225-55. PubMed ID: 225710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target gland functional status in patients with non-Cushing's pituitary macroadenomas undergoing transsphenoidal microsurgery.
    Garg MK; Tandon N; Gupta N; Varma A; Singh VP
    J Assoc Physicians India; 2001 Feb; 49():221-6. PubMed ID: 11225134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant GH deficiency after long-term cure by surgery in adult patients with Cushing's disease.
    Pecori Giraldi F; Andrioli M; De Marinis L; Bianchi A; Giampietro A; De Martin M; Sacco E; Scacchi M; Pontecorvi A; Cavagnini F
    Eur J Endocrinol; 2007 Feb; 156(2):233-9. PubMed ID: 17287413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired growth hormone secretion in patients operated for pituitary adenomas.
    Hoeck HC; Bang F; Laurberg P
    Growth Regul; 1994 Jun; 4(2):63-7. PubMed ID: 7950904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism.
    Procopio M; Maccario M; Savio P; Valetto MR; Aimaretti G; Grottoli S; Oleandri SE; Baffoni C; Tassone F; Arvat E; Camanni F; Ghigo E
    Minerva Endocrinol; 1999; 24(3-4):107-11. PubMed ID: 10953725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of transsphenoidal surgery for Cushing's disease: a high remission rate in ACTH-secreting macroadenomas.
    Fomekong E; Maiter D; Grandin C; Raftopoulos C
    Clin Neurol Neurosurg; 2009 Jun; 111(5):442-9. PubMed ID: 19200645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 67.